scispace - formally typeset
Search or ask a question
Institution

Tehran University of Medical Sciences

EducationTehran, Iran
About: Tehran University of Medical Sciences is a education organization based out in Tehran, Iran. It is known for research contribution in the topics: Population & Cancer. The organization has 35661 authors who have published 57234 publications receiving 878523 citations. The organization is also known as: TUMS.


Papers
More filters
Journal ArticleDOI
Valery L. Feigin1, Valery L. Feigin2, Theo Vos3, Theo Vos1, Fares Alahdab4, Arianna Maever L. Amit5, Arianna Maever L. Amit6, Till Bärnighausen7, Till Bärnighausen8, Ettore Beghi9, Mahya Beheshti10, Prachi Chavan11, Michael H. Criqui12, Rupak Desai13, Samath D Dharmaratne3, Samath D Dharmaratne1, Samath D Dharmaratne14, E. Ray Dorsey15, Arielle Wilder Eagan16, Arielle Wilder Eagan7, Islam Y. Elgendy7, Irina Filip17, Irina Filip18, Simona Giampaoli19, Giorgia Giussani9, Nima Hafezi-Nejad20, Nima Hafezi-Nejad5, Michael K. Hole21, Takayoshi Ikeda2, Catherine O. Johnson1, Rizwan Kalani3, Khaled Khatab22, Khaled Khatab23, Jagdish Khubchandani24, Daniel Kim25, Walter J. Koroshetz, Vijay Krishnamoorthy3, Vijay Krishnamoorthy26, Rita Krishnamurthi2, Xuefeng Liu27, Warren D. Lo28, Warren D. Lo29, Giancarlo Logroscino30, George A. Mensah31, George A. Mensah32, Ted R. Miller33, Ted R. Miller34, Salahuddin Mohammed35, Salahuddin Mohammed36, Ali H. Mokdad3, Ali H. Mokdad1, Maziar Moradi-Lakeh37, Shane D. Morrison27, Veeresh Kumar N. Shivamurthy38, Mohsen Naghavi1, Mohsen Naghavi3, Emma Nichols1, Bo Norrving39, Christopher M Odell1, Elisabetta Pupillo9, Amir Radfar40, Gregory A. Roth1, Gregory A. Roth3, Azadeh Shafieesabet41, Aziz Sheikh7, Aziz Sheikh42, Sara Sheikhbahaei5, Jae Il Shin43, Jasvinder A. Singh44, Jasvinder A. Singh45, Timothy J. Steiner46, Timothy J. Steiner47, Lars Jacob Stovner47, Mitchell T. Wallin48, Mitchell T. Wallin49, Jordan Weiss50, Chenkai Wu26, Joseph R. Zunt3, Jaimie D. Adelson1, Christopher J L Murray1, Christopher J L Murray3 
TL;DR: A large and increasing number of people have various neurological disorders in the US, with significant variation in the burden of and trends in neurological disorders across the US states, and the reasons for these geographic variations need to be explored further.
Abstract: IMPORTANCE Accurate and up-to-date estimates on incidence, prevalence, mortality, and disability-adjusted life-years (burden) of neurological disorders are the backbone of evidence-based health care planning and resource allocation for these disorders. It appears that no such estimates have been reported at the state level for the US. OBJECTIVE To present burden estimates of major neurological disorders in the US states by age and sex from 1990 to 2017. DESIGN, SETTING, AND PARTICIPANTS This is a systematic analysis of the Global Burden of Disease (GBD) 2017 study. Data on incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) of major neurological disorders were derived from the GBD 2017 study of the 48 contiguous US states, Alaska, and Hawaii. Fourteen major neurological disorders were analyzed: stroke, Alzheimer disease and other dementias, Parkinson disease, epilepsy, multiple sclerosis, motor neuron disease, migraine, tension-type headache, traumatic brain injury, spinal cord injuries, brain and other nervous system cancers, meningitis, encephalitis, and tetanus. EXPOSURES Any of the 14 listed neurological diseases. MAIN OUTCOME AND MEASURE Absolute numbers in detail by age and sex and age-standardized rates (with 95% uncertainty intervals) were calculated. RESULTS The 3 most burdensome neurological disorders in the US in terms of absolute number of DALYs were stroke (3.58 [95% uncertainty interval [UI], 3.25-3.92] million DALYs), Alzheimer disease and other dementias (2.55 [95% UI, 2.43-2.68] million DALYs), and migraine (2.40 [95% UI, 1.53-3.44] million DALYs). The burden of almost all neurological disorders (in terms of absolute number of incident, prevalent, and fatal cases, as well as DALYs) increased from 1990 to 2017, largely because of the aging of the population. Exceptions for this trend included traumatic brain injury incidence (−29.1% [95% UI, −32.4% to −25.8%]); spinal cord injury prevalence (−38.5% [95% UI, −43.1% to −34.0%]); meningitis prevalence (−44.8% [95% UI, −47.3% to −42.3%]), deaths (−64.4% [95% UI, −67.7% to −50.3%]), and DALYs (−66.9% [95% UI, −70.1% to −55.9%]); and encephalitis DALYs (−25.8% [95% UI, −30.7% to −5.8%]). The different metrics of age-standardized rates varied between the US states from a 1.2-fold difference for tension-type headache to 7.5-fold for tetanus; southeastern states and Arkansas had a relatively higher burden for stroke, while northern states had a relatively higher burden of multiple sclerosis and eastern states had higher rates of Parkinson disease, idiopathic epilepsy, migraine and tension-type headache, and meningitis, encephalitis, and tetanus. CONCLUSIONS AND RELEVANCE There is a large and increasing burden of noncommunicable neurological disorders in the US, with up to a 5-fold variation in the burden of and trends in particular neurological disorders across the US states. The information reported in this article can be used by health care professionals and policy makers at the national and state levels to advance their health care planning and resource allocation to prevent and reduce the burden of neurological disorders.

212 citations

Journal ArticleDOI
25 Sep 2020-PLOS ONE
TL;DR: It is recommended that improving vitamin D status in the general population and in particular hospitalized patients has a potential benefit in reducing the severity of morbidities and mortality associated with acquiring COVID-19.
Abstract: Background To investigate the association between serum 25-hydroxyvitamin D levels and its effect on adverse clinical outcomes, and parameters of immune function and mortality due to a SARS-CoV-2 infection. Study design The hospital data of 235 patients infected with COVID-19 were analyzed. Results Based on CDC criteria, among our study patients, 74% had severe COVID-19 infection and 32.8% were vitamin D sufficient. After adjusting for confounding factors, there was a significant association between vitamin D sufficiency and reduction in clinical severity, inpatient mortality serum levels of C-reactive protein (CRP) and an increase in lymphocyte percentage. Only 9.7% of patients older than 40 years who were vitamin D sufficient succumbed to the infection compared to 20% who had a circulating level of 25(OH)D< 30 ng/ml. The significant reduction in serum CRP, an inflammatory marker, along with increased lymphocytes percentage suggest that vitamin D sufficiency also may help modulate the immune response possibly by reducing risk for cytokine storm in response to this viral infection. Conclusion Therefore, it is recommended that improving vitamin D status in the general population and in particular hospitalized patients has a potential benefit in reducing the severity of morbidities and mortality associated with acquiring COVID-19.

211 citations

Journal ArticleDOI
TL;DR: Nausea, vomiting, Central Nervous System (CNS) depression, tachycardia, and seizure are the most common findings in this kind of poisoning, and cardiopulmonary arrest was found as the cause of death in cases who had ingested more than 5000 mg tramadol.
Abstract: Tramadol as a centrally acting analgesic is extensively used in the management of moderate to severe pain. It slightly affects opioid receptors and inhibits the reuptake of norepinephrin and serotonin in the CNS. There are reports about toxicity and abuse of tramadol. The objective of the present study was to evaluate epidemiology of intentional tramadol intoxications. All poisoning cases that admitted to Loghman-Hakim Hospital Poison Center from April to May 2007 were studied. A total of 114 cases (82 men and 32 women) of intentional tramadol intoxications with the median age of 23.66 +/- 6.87 years (range 16-54 years) were identified. Other illicit drugs were found to be used in combination with tramadol in some of the cases, which among them benzodiazepines were the most common. Tramadol overdose has been one of the most frequent causes of drug poisoning in the country in the recent years, especially in male young adults with history of substance abuse and mental disorders. Nausea, vomiting, Central Nervous System (CNS) depression, tachycardia, and seizure are the most common findings in this kind of poisoning. Cardiopulmonary arrest was found as the cause of death in cases who had ingested more than 5000 mg tramadol.

211 citations

Journal ArticleDOI
16 Oct 2017-BMJ
TL;DR: Time varying confounding affected by previous exposure is explained and three causal methods proposed to appropriately adjust for this potential bias are outlined: inverse-probability-of-treatment weighting, the parametric G formula, and G estimation.
Abstract: Many exposures of epidemiological interest are time varying, and the values of potential confounders may change over time leading to time varying confounding. The aim of many longitudinal studies is to estimate the causal effect of a time varying exposure on an outcome that requires adjusting for time varying confounding. Time varying confounding affected by previous exposure often occurs in practice, but it is usually adjusted for by using conventional analytical methods such as time dependent Cox regression, random effects models, or generalised estimating equations, which are known to provide biased effect estimates in this setting. This article explains time varying confounding affected by previous exposure and outlines three causal methods proposed to appropriately adjust for this potential bias: inverse-probability-of-treatment weighting, the parametric G formula, and G estimation.

211 citations

Journal ArticleDOI
TL;DR: Results indicate that genistein pretreatment ameliorates Aβ-induced impairment of short-term spatial memory in rats through an estrogenic pathway and by inducing attenuation of oxidative stress.

210 citations


Authors

Showing all 35946 results

NameH-indexPapersCitations
Graeme J. Hankey137844143373
Paul D.P. Pharoah13079471338
Jerome Ritz12064447987
Reza Malekzadeh118900139272
Robert N. Weinreb117112459101
Javad Parvizi11196951075
Omid C. Farokhzad11032964226
Ali Mohammadi106114954596
Alexander R. Vaccaro102117939346
John R. Speakman9566734484
Philip J. Devereaux94443110428
Rafael Lozano94265126513
Mohammad Abdollahi90104535531
Ingmar Skoog8945828998
Morteza Mahmoudi8333426229
Network Information
Related Institutions (5)
Mashhad University of Medical Sciences
18.7K papers, 252.5K citations

97% related

Isfahan University of Medical Sciences
19.5K papers, 248.6K citations

95% related

Tarbiat Modares University
32.6K papers, 526.3K citations

89% related

Shahid Beheshti University
21K papers, 293.7K citations

88% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023105
2022524
20216,041
20206,181
20195,322
20184,885